You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 15, April 15, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in JAMA
 Topic Collections
 •Nutritional and Metabolic Disorders
 •Metabolism
 •Cardiovascular System
 •Diet
 •Cardiovascular Disease/ Myocardial Infarction
 •Endocrine Diseases
 •Diabetes Mellitus
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Low–Glycemic Index vs High–Cereal Fiber Diet in Type 2 Diabetes—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: Drs Weickert and Pfeiffer raise important issues concerning the value of nonviscous (insoluble) wheat fiber in the prevention and treatment of type 2 diabetes and the potentially important role of other measures in addition to HbA1C and fasting blood glucose to provide a complete picture of changes in glycemic health. Our assessment of the literature and our own studies suggest that wheat fiber supplementation, such as wheat bran, has little effect on routine measures of blood glucose control in short-term studies (≤3 months)1 and no effect on serum lipids in the short-term.2 However, we agree that very significant benefits in diabetes incidence and heart disease have been seen for those who choose the higher fiber or "whole-wheat" option as cereal foods in longer-term cohort studies.3-5 The reasons for this inconsistency between short-term trials with markers of glycemic control compared with long-term studies with disease end points require . . . [Full Text of this Article]

David J. A. Jenkins, MD
Clinical Nutrition and Risk Factor Modification Center
St Michael's Hospital
Toronto, Ontario, Canada

Cyril W. C. Kendall, PhD
cyril.kendall@utoronto.ca
Department of Nutritional Sciences

Gail McKeown-Eyssen, PhD
Dalla Lana School of Public Health
University of Toronto
Toronto



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Effect of a Low–Glycemic Index or a High–Cereal Fiber Diet on Type 2 Diabetes: A Randomized Trial
David J. A. Jenkins, Cyril W. C. Kendall, Gail McKeown-Eyssen, Robert G. Josse, Jay Silverberg, Gillian L. Booth, Edward Vidgen, Andrea R. Josse, Tri H. Nguyen, Sorcha Corrigan, Monica S. Banach, Sophie Ares, Sandy Mitchell, Azadeh Emam, Livia S. A. Augustin, Tina L. Parker, and Lawrence A. Leiter
JAMA. 2008;300(23):2742-2753.
ABSTRACT | FULL TEXT  

RELATED LETTER

Low–Glycemic Index vs High–Cereal Fiber Diet in Type 2 Diabetes
Martin O. Weickert and Andreas F. H. Pfeiffer
JAMA. 2009;301(15):1538.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.